CopyMark Law Group
4.9/5
Drawing for ADEX

USPTO serial 98740048

ADEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MINAYA, NYASIA ALYSSA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alyssa M. Worsham

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
016Printed publications, namely, research papers, articles, digests in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; Printed publications, namely, research papers, articles, digests in the fields of physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, pharmaceuticals, technology, computer science, chemical engineering, medicine, and healthcareACTIVE—
035Compilation of information into computer databases; data processing services; scientific, chemical, physical, and biological data analysis services for others; scientific, chemical, physical, and biological data processing and analysis services for others; promoting collaboration within the scientific, medical, clinical and research communities to achieve advances in those fields using artificial intelligence, machine learning, deep learning and reinforcement learning technologies; none of the foregoing being provided in the fields of film production, distribution, or exhibitionACTIVE—
042technical scientific consultation and product development for others in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; development of materials, software, artificial intelligence, chemicals, and pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; research and development of treatment protocols for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in science, chemistry, biology, physics, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, technology, chemical engineering, computer science, medicine and healthcare, and design and optimization of molecules, materials, catalysts, chemicals, and drugs; chemistry consultation services in the nature of drugs, materials, chemicals, and molecular discovery services; product development services; chemical research and chemistry consultation in the field of drug, materials, chemicals, and molecular development; providing online non-downloadable software for simulations for drug, materials, chemicals, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; software as a services (SAAS) services in the nature of hosting software for cloud-based computing for the development of new molecules and designing and discovering molecules, drugs, and other molecular products; research and development of pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; design and development of computer software; providing online non-downloadable computer software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; platform as a service (PAAS) featuring computer software platforms using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; platform as a service (PAAS) featuring artificial intelligence computer software platforms for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; software as a service (SAAS) featuring software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; software as a service (SAAS) featuring artificial intelligence software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; providing online non-downloadable computer software for scientific analysis; providing online non-downloadable software, namely, software for use in designing and developing artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, computational chemistry, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in determining properties or physical characteristics of organic compounds, inorganic compounds, organic materials, inorganic materials; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services; Industrial research services in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; Industrial analysis in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; computer modeling services; scientific research into organic compounds; scientific services, namely, analysis of organic compounds, inorganic compounds, organic materials, inorganic materials; crystal analysis services for scientific research purposes; research in the field of computer natural language processing; medical and scientific research in the field of machine learning and models to evaluate drug compounds pharmacological properties; medical and scientific research services in the field of machine learning models to evaluate bioactivity and pharmacological properties of drug compounds; medical and scientific research services in the field of machine learning models to generate and evaluate drug compounds for specific pharmacological and bioactivity effects and results; medical and scientific research services in the field of machine learning models to evaluate drug compounds and their efficacy and side effects for purposes of clinical trials; medical and scientific research services in the field of machine learning models to generate and evaluate treatment protocols for purposes of clinical trials; computerized electronic data verification services, in the nature of data analysis for the verification of scientific, chemical, physical or biological data; data automation and collection services using proprietary software to collect, evaluate, analyze and collect data in the field of scientific, chemical, physical or biological analysis; data compilation services for research purposes in the field of scientific, chemical, physical or biological analysis; data management services, namely, management of scientific, chemical, physical or biological data; none of the foregoing being provided in the fields of film production, distribution, or exhibitionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 20, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 20, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 16, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 22, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 22, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2025DOCKASSIGNED TO EXAMINER—
Jan 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 9, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance